ASTER One Year Later A New Business Model for Postmarketing Reporting.

Slides:



Advertisements
Similar presentations
Managing a clinical incident
Advertisements

Meaningful Use and Health Information Exchange
Improving Spontaneous Reporting: A new business model Incorporating postmarket medical product safety data collection into the clinical practice workflow.
Medical Education Outcomes Research Frederick Chen, MD, MPH Center for Primary Care Research Agency for Healthcare Research and Quality June 26, 2003.
Ronald T. Ackermann, MD, MPH Indiana University School of Medicine
IT in Healthcare IT Careers in Healthcare Emerging opportunities for IT professionals Prof. Vance Wilson Arizona State University.
Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimers Disease Drug: COMET-AD.
10/20/ The Pharmaceutical Industry and Their Influence on Pain Management in the ED J. David Haddox, DDS, MD VP, Risk Management & Health Policy.
CCHSA Accreditation: New Standards for Managing Medications
S-Curves & the Zero Bug Bounce:
Introduction Discussion Results Mobile Health Clinics are transportable health care units that deliver high-value community based health care to underserved.
2008 Johns Hopkins Bloomberg School of Public Health Setting Up a Smoking Cessation Clinic Sophia Chan PhD, MPH, RN, RSCN Department of Nursing Studies.
5th Annual PBM Pharmacy Informatics Conference
N101Y Health Information Technology Module
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Felisha Rohan-Minjares, MD Assistant Professor, FCM Director of Cultural Competency Curriculum Development Office of Diversity.
ANKIT (2209) PUJIT KAMAL (2335) CONTENTS 1.INTRODUCTION 2.BENEFITS OF EXECUTION OF DESIRED IT SOLUTION IN FUNCTIONAL AREAS 3.AREAS COVERED BY HIT (HEALTH.
CHAPTER © 2011 The McGraw-Hill Companies, Inc. All rights reserved. 2 The Use of Health Information Technology in Physician Practices.
A Librarian by Any Other Name The Role of the Informationist on a Medical School Research Team.
TIGER Standards & Interoperability Collaborative Informatics and Technology in Nursing.
1 UCDHS Vendor Relations Policy Development & Implementation Teresa Porter, CHC - Chief Compliance Officer David Levine, JD - Legal Counsel Allan Siefkin,
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
Safety, Quality and Information Technology and NHII David W. Bates, Medical Director of Clinical and Quality Analysis, Partners Healthcare Chief, Division.
2 The Use of Health Information Technology in Physician Practices.
MONDAY, 5:00 – 5:30PM Innovative Opportunities for Patient Safety Using Electronic Health Record (EHR) Data: Perspectives from the FDA FDA to CONNECT Mitra.
Welcome to my presentation on Health Literacy in the Community By Sharon Herring.
Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimer’s Disease Drugs: COMET-AD.
Darren A. DeWalt, MD, MPH Division of General Internal Medicine Maihan B. Vu, Dr.PH, MPH Center for Health Promotion and Disease Prevention University.
Accelerated Team Performance
Shane Sparks, MD 1 ; J. Benjamin Guise, MD 1 ; Carol R. Thrush, EdD 2 1 UAMS Department of Psychiatry, 2 UAMS Office of Educational Development Background.
Introduction to Healthcare and Public Health in the US Delivering Healthcare (Part 2) Lecture a This material (Comp1_Unit3a) was developed by Oregon Health.
Module 3. Session DCST Clinical governance
Leading a Patient Safety Program Madeleine Biondolillo, MD Massachusetts Department of Public Health Gordon Schiff, MD Brigham & Women’s Hospital; Harvard.
Responsibilities and Principles of Drug Administration
Introducing the Medication Recording System Schedule Ed Castagna Mom & Pop’s Small Business Services.
Copyright © 2009 by The McGraw-Hill Companies, Inc. All Rights Reserved. McGraw-Hill Chapter 4 Electronic Health Records in the Hospital Electronic Health.
Implications for the Use of Tissue in Research P. Pearl O’Rourke, MD Partners HealthCare Boston, MA.
Assessing Weight Through Documentation of Body Mass Index (BMI) in Health Plan Populations Sarah Sampsel, MPH Research Scientist June 2008.
Elizabeth A. Martinez, MD, MHS Johns Hopkins Medical Institutions September 10, 2008 Organization of Care and Outcomes in Cardiac Surgery AHRQ grant 1K08HS A1.
Overview of Issues: Barriers to Developing EHR in This Field Constance Weisner, DrPH, MSW Jennifer Mertens, PhD Stacy Sterling, MSW, MPH Narrowing the.
Successful Development of a Simulation Center Charles N. Pozner, MD Medical Director, Neil and Elise Wallace STRATUS Center for Medical Simulation Brigham.
National Institute of Standards and Technology Technology Administration U.S. Department of Commerce NIST/ATP Initiatives in Telehealth Richard N. Spivack,
HL7 Child Health Work Group Update HL7 EHR-Public Health Task Force Andy Spooner, MD CMIO, Cincinnati Children’s Hospital & Medical Center Co Chair, HL7.
Beyond ePrescribing Factors Influencing Patient Safety in Medical Group Practices - September 26 th, 2007 AHRQ 2007: Improving Healthcare, Improving Live.
Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation.
FDA Regulation Economically Harmful & Morally Indefensible.
Introduction.
Postmarketing Pharmacovigilance Practice at FDA Lanh Green, Pharm.D., M.P.H. Office of Surveillance and Epidemiology June 21, 2006.
The Path to a Successful Career in Academic Medicine Thomas R. Martin, M.D. Professor and Chief of Medicine VA Puget Sound Health Care System University.
Overview: Common Formats Overview: Common Formats Event Reporting vs. Surveillance Future of Automation Prepared for the HL-7 CQI Meeting CDR A. Gretchen.
The CDRH Software Message (October 19, 2002) John F Murray Jr.. Center for Devices & Radiological Health US Food and Drug Administration
1 Copyright © 2009, 2006, 2003, 2000, 1997, 1994 by Saunders, an imprint of Elsevier Inc. Chapter 23 Nursing Informatics.
Curriculum Development: an Overview of 6 Steps MAJ Heather O’Mara, DO, FAAFP Faculty Development Fellow.
All Hands Electronic Information Integrity Call White Paper An Introduction to the Current State of EMR – et.al. R. L. Chamberlain, Ph.D.
Postmarket Assessment in the U.S. and Unique Device Identifiers (UDI)
Security Research Institute
March 30, 2011 Presenter: Michael Flynn
MONDAY, 5:00 – 5:30PM Innovative Opportunities for Patient Safety Using Electronic Health Record (EHR) Data: Perspectives from the FDA FDA to CONNECT Mitra.
The Elements of Health Care Quality and Current Improvement Efforts
Reporting Approaches and Best Practices Jennifer Benjamin NCQA
Bounded Rationality Herbert A. Simon.
Caring for the Critically Ill Patient
Medication Use Pattern Mining for Childhood Pneumonia Using Six Year Inpatient Electronic Medical Records in a Shanghai Hospital, China Chunlei Tang, PhD1,2,3,
Bell work Think back to our previous discussions concerning HIPAA. Research the following: Name at least 5-7 items that would be included in our Electronic.
Comparing automated mental health screening to manual processes in a health care system Josh biber.
Information for Network Providers
Electronic Health Record Update
Personal Wellbeing.
Tobey Clark, Director*, Burlington USA
AHRQ Safety Program for Improving Antibiotic Use
Presentation transcript:

ASTER One Year Later A New Business Model for Postmarketing Reporting

Session Participants Michael Ibara (Pfizer) – Setting the stage – ASTER Landen Bain (CDISC Liaison to Healthcare) – Experiences in ASTER – Reflections on role of not for profits Atif Zafar, MD (Associate Professor of Medicine, Indiana University / Regenstrief Institute Inc.) – Reporting events and patient outcomes related to therapy Lise Stevens ( Data Standards Project Manager, FDA Office of Critical Path Programs ) – FDA’s work – Results

“Unfortunately, many health professionals do not think to report adverse events that might be associated with medications or devices to the Food and Drug Administration (FDA) or to the manufacturer. That needs to change...” Introducing MEDWatch: A New Approach to Reporting Medication and Device Adverse Effects and Product Problems David A. Kessler, MD, for the Working Group JAMA, June 2, Vol 269, No to YEARS

10:30:00 In the greater metro Boston area, a doctor affiliated with Brigham and Women’s Hospital or Mass General Hospital discontinues a patient’s drug due to an adverse event. If the doctor is participating in a certain effort, here’s what will happen…

Screen Shots

Screen shots #2

Screen shots #3

Screen shots #4

Screen shots #5

Screen shots #6

Screen shots #7

10:30:00 The doctor goes back to seeing the patient 10:31:00

10:40:00 A MedWatch report* derived directly from the source document (EHR), validated by the doctor, is delivered to FDA * The report is MedDRA coded and has an initial ‘serious/nonserious’ assessment

Improving The Reporting of Adverse Events and Making Spontaneous Reporting Work

The ASTER Collaboration… Partners Healthcare CDISC CRIX / CERNER FDA Pfizer

Scalable Model for “Triggered” Reporting Public / Private Organization Computer-assisted Surveillance EHR Provider / Patient Manufacturers Regulators Data collection incorporated at point of care Very light footprint for EMR Portable to other EMRs, applications Can take advantage of further developments in automated recognition Global solution Structured by safety elements requirements (E2B/HL7 ICSR) Mediated through RFD, Web Forms 15

HOW DID IT GO?

*ASTER started Nov Ambulatory care physicians Completing June 2009 > 200 Reports Sent to FDA David Westfall Bates, MD, M.Sc. Chief of the Division of General Internal Medicine at the Brigham and Women's Hospital; Professor of Medicine at Harvard Medical School and Professor of Health Policy and Management at the Harvard School of Public Health (Co- Director of the Program in Clinical Effectiveness) Jeffrey A. Linder, MD, MPH, FACP - PI of *ASTER Assistant Professor of Medicine, Harvard Medical School Division of General Medicine and Primary Care, Brigham and Women's Hospital, Boston MA

RESULTS TO DATE...Physician interaction – ”a blink (60 secs)”...time for reviewing instructions - no instructions needed...searching existing data sources - no searching required...gathering and maintaining the data needed - transparent...completing and reviewing the information - minimal interaction

Information in Reports Approximately 20% of reported events were deemed ‘Serious’ defined as: Matching regulatory serious outcome Coded event matching an ‘always serious list’ 100% had height/weight, lab data

Physician Reporting 91% of participating physicians had submitted no ADE reports in the prior year During the study, participants reported an average of approximately 5 reports in a 3 month time period All participants reported at least 1 ADE

Physician Acceptance What could make it better? Majority would like feedback from FDA e.g., Actions taken on the report e.g., Acknowledgement of report Vast majority would like to be able to view national data of similar reports 87% thought ASTER would improve their ability to accurately report drug risks “a lot”

“Took a while for the screen to pop up” “Too many clicks, screen too slow” “Takes a little extra time, but worth it” Dislikes …

“Easy, pops right up - Nothing to do later, can do it right on the spot.” “very quick, automatic load” “help to pt safety” Likes …

"Overall ASTER was well-accepted by the participating physicians, who felt it was unobtrusive and who saw the public health potential. “The clinicians, most of whom submitted no reports in the prior year - submitted over 200 reports in 3 months." Jeffrey A. Linder, MD, MPH, FACP Brigham and Women ’ s Hospital / Partners Healthcare PI on ASTER Study

“Unfortunately, many health professionals do not think to report adverse events that might be associated with medications or devices to the Food and Drug Administration (FDA) or to the manufacturer. That needs to change...” Introducing MEDWatch: A New Approach to Reporting Medication and Device Adverse Effects and Product Problems David A. Kessler, MD, for the Working Group JAMA, June 2, Vol 269, No

Herbert Simon Richard King Mellon University Professor of Computer Science and Psychology at Carnegie Mellon University (b. Milwaukee d. Pittsburgh 2001) 52-year career in artificial intelligence, psychology, administration and economics. Nobel Prize Economics 1975: Won A.M. Turing Award for his work in computer science 1978: Received the Alfred Nobel Memorial Prize in Economic Sciences 1986: National Medal of Science 1993: American Psychological Association Award for Outstanding Lifetime Contributions to Psychology 1994: One of only 14 foreign scientists ever to be inducted into the Chinese Academy of Sciences 1995: Two prominent awards - International Joint Conferences on Artificial Intelligence (the Award for Research Excellence) and the American Society of Public Administration (the Dwight Waldo Award) 1996: Inducted into the Automation Hall of Fame because of his pioneering work in the field of artificial intelligence Received major national awards from the Association for Computing Machinery, the American Political Science Association, the Academy of Management, the Operations Research Society and the Institute of Management Science, among others. Books include Administrative Behavior; Human Problem Solving, jointly with Allen Newell; The Sciences of the Artificial; Scientific Discovery, with Pat Langley, Gary Bradshaw, and Jan Zytkow; Models of Bounded Rationality; Models of Thought; Models of Discovery; and his autobiography, Models of My Life.

“What information consumes is rather obvious: it consumes the attention of its recipients. Hence a wealth of information creates a poverty of attention, and a need to allocate that attention efficiently among the overabundance of information sources that might consume it." "What information consumes is rather obvious: it consumes the attention of its recipients. Hence a wealth of information creates a poverty of attention "What information consumes is rather obvious: it consumes the attention of its recipients. Simon, H. A. (1971), "Designing Organizations for an Information-Rich World", written at Baltimore, MD, in Martin Greenberger, Computers, Communication, and the Public Interest, The Johns Hopkins Press, ISBN X

"A design representation suitable to a world in which the scarce factor is information may be exactly the wrong one for a world in which the scarce factor is attention.” Herbert Simon The Sciences of the Artificial p.144

"A design representation suitable to a world in which the scarce factor is information may be exactly the wrong one for a world in which the scarce factor is attention. Herbert Simon The Sciences of the Artificial p.144 The task is not to design information- distributing systems but intelligent information-filtering systems.“

We’ve electronified our old business model We need business models that will take advantage of digitized healthcare data

Scalable Model for “Triggered” Reporting Public / Private Organization Computer-assisted Surveillance EHR Provider / Patient Manufacturers Regulators 15

What does ASTER solve? Problems for… The reporter The EHR owner The Regulator* * and manufacturer

Does this matter…

Imagine… Collecting all drug discontinuations due to AEs… Interfacing seamlessly with any clinical system using ‘triggers’ to recognize AEs… Having as much safety data from source docs as we do claims data… Having a denominator from each reporting institution…

This is not your fathers spontaneous reporting…

By utilizing digitized healthcare data and new business models we can develop, in the near future, a new type of ‘triggered reporting’ system, which is pervasive, efficient, delivers high quality information, and improves patient safety.

Lessons…?